A detailed history of Brown Advisory Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Brown Advisory Inc holds 11,969 shares of HAE stock, worth $746,386. This represents 0.0% of its overall portfolio holdings.

Number of Shares
11,969
Previous 440,169 97.28%
Holding current value
$746,386
Previous $35.4 Million 97.36%
% of portfolio
0.0%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

SELL
$71.16 - $93.38 $30.5 Million - $40 Million
-428,200 Reduced 97.28%
11,969 $934,000
Q3 2024

Nov 13, 2024

BUY
$72.45 - $91.58 $7.1 Million - $8.98 Million
98,027 Added 28.65%
440,169 $35.4 Million
Q2 2024

Aug 14, 2024

BUY
$81.24 - $97.37 $27.8 Million - $33.3 Million
342,142 New
342,142 $28.3 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.2B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Brown Advisory Inc Portfolio

Follow Brown Advisory Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Inc, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Inc with notifications on news.